Prasad Raju, CFO of CRISPR Therapeutics AG ($CRSP), sold about 4.7 million dollars worth of company shares on the open market nine times over the past year. His most recent sale occurred on January 22, 2026. These transactions rank him 2,024th among 11,678 insiders in our database by total sales value, below the average of 8.6 million dollars per seller across about 6.4 trades. Raju made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Common Shares | 6250 | $0.00 | 19,273.0000 | 95,985,312 | 47.99% | 0.01% |
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Restricted Stock Units | 6250 | $0.00 | 12,500.0000 | 95,985,312 | 33.33% | 0.01% |
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Restricted Stock Units | 27500 | $0.00 | 27,500.0000 | 95,985,312 | 9999.99% | 0.03% |
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Stock Option (Right to Buy) | 38499 | $0.00 | 38,499.0000 | 95,985,312 | 9999.99% | 0.04% |
| March 23, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 3708 | $46.78 | 15,565.0000 | 95,985,312 | 19.24% | 0.00% |
| March 16, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | G | Common Shares | 750 | $0.00 | 13,023.0000 | 95,985,312 | 5.45% | 0.00% |
| March 14, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Restricted Stock Units | 6875 | $0.00 | 20,625.0000 | 95,985,312 | 25.00% | 0.01% |
| March 16, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 5848 | $48.26 | 17,794.0000 | 95,985,312 | 24.74% | 0.01% |
| March 16, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 4021 | $48.26 | 13,773.0000 | 95,985,312 | 22.60% | 0.00% |
| March 14, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Restricted Stock Units | 10000 | $0.00 | 10,000.0000 | 95,985,312 | 50.00% | 0.01% |
| March 14, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Common Shares | 10000 | $0.00 | 16,767.0000 | 95,985,312 | 147.78% | 0.01% |
| March 14, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Common Shares | 6875 | $0.00 | 23,642.0000 | 95,985,312 | 41.00% | 0.01% |
| Jan. 22, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Stock Option (Right to Buy) | 34972 | $0.00 | 41,667.0000 | 95,300,233 | 45.63% | 0.04% |
| Jan. 22, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 34972 | $60.19 | 6,767.0000 | 95,300,233 | 83.79% | 0.04% |
| Jan. 22, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Common Shares | 34972 | $45.15 | 41,739.0000 | 95,300,233 | 516.80% | 0.04% |
| Jan. 6, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 5763 | $60.21 | 6,767.0000 | 95,300,233 | 45.99% | 0.01% |
| Jan. 6, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Common Shares | 23361 | $45.15 | 30,128.0000 | 95,300,233 | 345.22% | 0.02% |
| Jan. 6, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Common Shares | 6339 | $44.31 | 36,467.0000 | 95,300,233 | 21.04% | 0.01% |
| Jan. 6, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 18933 | $60.18 | 17,534.0000 | 95,300,233 | 51.92% | 0.02% |
| Jan. 6, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 5004 | $60.00 | 12,530.0000 | 95,300,233 | 28.54% | 0.01% |
| Jan. 6, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Stock Option (Right to Buy) | 23361 | $0.00 | 76,639.0000 | 95,300,233 | 23.36% | 0.02% |
| Jan. 6, 2026 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Stock Option (Right to Buy) | 6339 | $0.00 | 7,493.0000 | 95,300,233 | 45.83% | 0.01% |
| Dec. 22, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 1000 | $56.89 | 6,767.0000 | 95,300,233 | 12.87% | 0.00% |
| Dec. 22, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 5472 | $56.33 | 7,767.0000 | 95,300,233 | 41.33% | 0.01% |
| Dec. 22, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 3528 | $55.10 | 13,239.0000 | 95,300,233 | 21.04% | 0.00% |
| Oct. 3, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Stock Option (Right to Buy) | 16500 | $0.00 | 16,500.0000 | 85,774,474 | 9999.99% | 0.02% |
| May 30, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Restricted Stock Units | 20000 | $0.00 | 20,000.0000 | 85,774,474 | 9999.99% | 0.02% |
| March 20, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Restricted Stock Units | 6250 | $0.00 | 18,750.0000 | 85,774,474 | 25.00% | 0.01% |
| March 20, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Common Shares | 6250 | $0.00 | 18,964.0000 | 85,774,474 | 49.16% | 0.01% |
| March 21, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 2197 | $41.23 | 16,767.0000 | 85,774,474 | 11.59% | 0.00% |
| March 14, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Common Shares | 10000 | $0.00 | 16,476.0000 | 85,774,474 | 154.42% | 0.01% |
| March 17, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 3762 | $41.80 | 12,714.0000 | 85,774,474 | 22.83% | 0.00% |
| March 14, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Restricted Stock Units | 10000 | $0.00 | 20,000.0000 | 85,774,474 | 33.33% | 0.01% |
| March 14, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Stock Option (Right to Buy) | 36666 | $0.00 | 36,666.0000 | 85,774,474 | 9999.99% | 0.04% |
| March 14, 2025 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Restricted Stock Units | 27500 | $0.00 | 27,500.0000 | 85,774,474 | 9999.99% | 0.03% |
| Oct. 16, 2024 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Stock Option (Right to Buy) | 18333 | $0.00 | 18,333.0000 | 0 | 9999.99% | 0.00% |
| Oct. 16, 2024 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Restricted Stock Units | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2024 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Stock Option (Right to Buy) | 36168 | $0.00 | 36,168.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2024 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2024 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | S | Common Shares | 3524 | $72.69 | 6,476.0000 | 0 | 35.24% | 0.00% |
| March 14, 2024 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Common Shares | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | M | Restricted Stock Units | 10000 | $0.00 | 30,000.0000 | 0 | 25.00% | 0.00% |
| Oct. 13, 2023 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Stock Option (Right to Buy) | 13832 | $0.00 | 13,832.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2023 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2023 | CRISPR Therapeutics AG | $CRSP | Prasad Raju | Chief Financial Officer | A | Restricted Stock Units | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |